InvestorsHub Logo
Followers 0
Posts 10
Boards Moderated 0
Alias Born 09/23/2014

Re: None

Thursday, 08/17/2017 8:49:14 PM

Thursday, August 17, 2017 8:49:14 PM

Post# of 12411
there is a total of 400 million authorized shares. With only 250 million out. The burn rate is really low. Besides Clarence being CEO, the next best thing is that the Universities are flipping the bill on the study. He does not need to go through that many shares to get to the finish line. There is no debt. They only spent $55k in the last quarter to run the company. Then 86k in R and D. Can you show me another Biotech company with this low of burn, no debt and in clinical trials?